Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum Carbonate Extended Dose Range in ESRD
NCT00150566Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lanthanum carbonate in hyperphosphatemia, sponsored by Takeda. Started Feb 2004; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00150566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150566.